Transformative Biotech Opens Huntsville Research Lab
The firm is utilizing the HudsonAlpha Primer Lab to accelerate development of its direct-to-PCR infectious disease test.
Updated on Oct. 29, 2026 in Biotech
Live Poll
Do you believe business incubators are a good way to foster economic growth in your community?
Transformative Biotech, a Colorado-based firm, has established research operations at the HudsonAlpha Institute for Biotechnology's Primer Lab in Huntsville as of October 2026. The move aims to accelerate development of its infectious disease testing technologies.
Why it matters
Securing space in the Primer Lab allows the company to leverage specialized molecular laboratory equipment and shared resources. This transition is intended to provide the empirical data required to advance the company's DirectAmp technology toward commercial partnerships.
The firm operates within 4,000 square feet of shared laboratory space at the Paul Propst Center. This facility provides the infrastructure required to test DirectAmp, a proprietary direct-to-PCR platform designed for pathogen identification.
The players
Transformative Biotech
A Colorado-based company focused on developing direct-to-PCR infectious disease diagnostic technologies.
HudsonAlpha Institute for Biotechnology
A Huntsville-based research organization that operates the Primer Lab incubator to support life sciences startups.
Mark Kelleher
The executive vice president of research and development at Transformative Biotech who is overseeing the Huntsville-based research efforts.
The details
DirectAmp technology allows for infectious disease testing using a direct-to-PCR process, which bypasses traditional sample preparation steps that often slow down nucleic acid amplification. By establishing a presence at the Primer Lab, the research team gains access to molecular laboratory equipment and mentorship provided through the Innovate Alabama-funded incubator. This infrastructure supports scaling the DirectAmp process across diverse clinical sample types to confirm diagnostic performance.
Timeline
September 24, 2026: HudsonAlpha officially opened the Primer Lab incubator.
October 2026: Transformative Biotech commenced research operations at the facility.
The Tech Race
Transformative Biotech joins the ranks of firms utilizing the Primer Lab to rapidly transition from concept to validated research. This move positions the company within a regional ecosystem competing to shorten the development lifecycle of molecular diagnostic tools.
This development serves as a precursor to future diagnostic commercialization, with no immediate products available for consumer or clinical use today. The company is currently focused on generating internal performance data to support upcoming partnership and licensing agreements.
The takeaway
The research transition signals a shift toward formal validation of the company's direct-to-PCR diagnostics platform. Watch for future performance data releases and announcements regarding commercial partnerships or grant funding milestones.
Further reading
Explore the broader Biotech sector to understand how research incubators are shaping the landscape of diagnostic innovation.
Source note: This article includes information reported by ColoradoBiz.
Live Poll
Do you believe business incubators are a good way to foster economic growth in your community?
